Hélène E. Aschmann

1.6k total citations · 2 hit papers
34 papers, 854 citations indexed

About

Hélène E. Aschmann is a scholar working on Economics and Econometrics, Oncology and General Health Professions. According to data from OpenAlex, Hélène E. Aschmann has authored 34 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 7 papers in Oncology and 6 papers in General Health Professions. Recurrent topics in Hélène E. Aschmann's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Lipoproteins and Cardiovascular Health (5 papers) and COVID-19 and healthcare impacts (5 papers). Hélène E. Aschmann is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Lipoproteins and Cardiovascular Health (5 papers) and COVID-19 and healthcare impacts (5 papers). Hélène E. Aschmann collaborates with scholars based in United States, Switzerland and Uganda. Hélène E. Aschmann's co-authors include Milo A. Puhan, Henock G. Yebyo, Dominik Menges, Jan Fehr, Tala Ballouz, Anja Domenghino, A Anagnostopoulos, Marco Kaufmann, Cynthia M. Boyd and Anja Frei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Hélène E. Aschmann

34 papers receiving 831 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study

2021 196 citations Dominik Menges, Tala Ballouz et al. PLoS ONE profile →
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study

2023 94 citations Tala Ballouz, Dominik Menges et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hélène E. Aschmann United States	16	258	198	136	124	119	34	854
Chia Siang Kow Malaysia	20	321 1.2×	104 0.5×	720 5.3×	85 0.7×	122 1.0×	104	1.4k
Faizan Mazhar Sweden	18	79 0.3×	51 0.3×	155 1.1×	68 0.5×	102 0.9×	64	964
Geneviève Durrieu France	24	322 1.2×	35 0.2×	158 1.2×	185 1.5×	176 1.5×	105	1.7k
Cristina Scavone Italy	26	216 0.8×	51 0.3×	468 3.4×	94 0.8×	211 1.8×	107	1.9k
Tanja Richter Germany	17	50 0.2×	154 0.8×	86 0.6×	46 0.4×	102 0.9×	30	1.3k
Sarah Louise Klingenberg Denmark	13	60 0.2×	67 0.3×	176 1.3×	35 0.3×	151 1.3×	22	948
Ida Fortino Italy	24	69 0.3×	74 0.4×	60 0.4×	280 2.3×	122 1.0×	108	1.9k
Olivia Leoni Italy	16	87 0.3×	42 0.2×	148 1.1×	60 0.5×	42 0.4×	82	753
Sallyann M. Coleman King United States	14	94 0.4×	50 0.3×	35 0.3×	60 0.5×	128 1.1×	28	1.2k

Countries citing papers authored by Hélène E. Aschmann

Since Specialization

Citations

This map shows the geographic impact of Hélène E. Aschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène E. Aschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène E. Aschmann more than expected).

Fields of papers citing papers by Hélène E. Aschmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène E. Aschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène E. Aschmann. The network helps show where Hélène E. Aschmann may publish in the future.

Co-authorship network of co-authors of Hélène E. Aschmann

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène E. Aschmann. A scholar is included among the top collaborators of Hélène E. Aschmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène E. Aschmann. Hélène E. Aschmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aschmann, Hélène E., Christopher A. Berger, Noah Kiwanuka, et al.. (2024). Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda. Open Forum Infectious Diseases. 11(11). ofae667–ofae667. 1 indexed citations

Aschmann, Hélène E., Christopher A. Berger, Achilles Katamba, et al.. (2024). Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda. SHILAP Revista de lepidopterología. 1(2). 83–89. 1 indexed citations

Terman, Samuel W., Hélène E. Aschmann, David W. Hutton, & James Burke. (2023). Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results. PLoS ONE. 18(3). e0282658–e0282658. 5 indexed citations

Chen, Ruijia, Marie‐Laure Charpignon, Erika Meza, et al.. (2023). Excess Mortality With Alzheimer Disease and Related Dementias as an Underlying or Contributing Cause During the COVID-19 Pandemic in the US. JAMA Neurology. 80(9). 919–919. 15 indexed citations

Ballouz, Tala, Dominik Menges, Hélène E. Aschmann, et al.. (2022). Individual-Level Evaluation of the Exposure Notification Cascade in the SwissCovid Digital Proximity Tracing App: Observational Study. JMIR Public Health and Surveillance. 8(5). e35653–e35653. 10 indexed citations

Chen, Yea‐Hung, Andrew Stokes, Hélène E. Aschmann, et al.. (2022). Excess natural-cause deaths in California by cause and setting: March 2020 through February 2021. PNAS Nexus. 1(3). pgac079–pgac079. 10 indexed citations

Menges, Dominik, Kyra D. Zens, Tala Ballouz, et al.. (2022). Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort. Nature Communications. 13(1). 4855–4855. 16 indexed citations

Domenghino, Anja, Hélène E. Aschmann, Tala Ballouz, et al.. (2022). Mental health of individuals infected with SARS-CoV-2 during mandated isolation and compliance with recommendations—A population-based cohort study. PLoS ONE. 17(3). e0264655–e0264655. 7 indexed citations

Aschmann, Hélène E., Alicia R. Riley, Ruijia Chen, et al.. (2022). Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic. Proceedings of the National Academy of Sciences. 119(40). e2210941119–e2210941119. 21 indexed citations

10.

Chen, Yea‐Hung, Alicia R. Riley, Kate A. Duchowny, et al.. (2022). COVID-19 mortality and excess mortality among working-age residents in California, USA, by occupational sector: a longitudinal cohort analysis of mortality surveillance data. The Lancet Public Health. 7(9). e744–e753. 19 indexed citations

11.

Ballouz, Tala, Dominik Menges, Hélène E. Aschmann, et al.. (2021). Adherence and Association of Digital Proximity Tracing App Notifications With Earlier Time to Quarantine: Results From the Zurich SARS-CoV-2 Cohort Study. International Journal of Public Health. 66. 16 indexed citations

12.

Menges, Dominik, Tala Ballouz, A Anagnostopoulos, et al.. (2021). Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS ONE. 16(7). e0254523–e0254523. 196 indexed citations breakdown →

13.

Aschmann, Hélène E., et al.. (2020). Benefit-harm balance of fingolimod in patients with MS: A modelling study based on FREEDOMS. Multiple Sclerosis and Related Disorders. 46. 102464–102464. 2 indexed citations

14.

Aschmann, Hélène E., Cynthia M. Boyd, Craig Robbins, et al.. (2019). Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment. BMJ Open. 9(8). e028438–e028438. 6 indexed citations

15.

Yebyo, Henock G., Hélène E. Aschmann, Marco Kaufmann, & Milo A. Puhan. (2019). Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants. American Heart Journal. 210. 18–28. 111 indexed citations

16.

Bennett, Wendy L., Hélène E. Aschmann, Milo A. Puhan, et al.. (2019). A benefit–harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. Journal of Clinical Epidemiology. 113. 92–100. 17 indexed citations

17.

Aschmann, Hélène E., Milo A. Puhan, Craig Robbins, et al.. (2019). Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling. Health and Quality of Life Outcomes. 17(1). 186–186. 9 indexed citations

18.

Yebyo, Henock G., Hélène E. Aschmann, & Milo A. Puhan. (2018). Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease. Annals of Internal Medicine. 2 indexed citations

19.

Yebyo, Henock G., Hélène E. Aschmann, Tsung Yu, & Milo A. Puhan. (2018). Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts. BMC Cardiovascular Disorders. 18(1). 97–97. 21 indexed citations

20.

Neuhaus, Claudia S., Björn Wagner, Hélène E. Aschmann, et al.. (2017). Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability. European Journal of Pharmaceutical Sciences. 104. 150–161. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact